SCHEMBL30633315

SCHEMBL30633315

CCN(C(=O)O)c1cc(-c2ccc3[nH]nc(N)c3c2)ccn1.CS(=O)(=O)c1ccc(NC(=O)Nc2cc(-c3ccc4[nH]nc(N)c4c3)ccn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 6/20 0.46
▸ JAK3 P52333 4/20 0.44
▸ PLK4 O00444 4/20 0.44
▸ AURKB Q96GD4 4/20 0.44
▸ CLK2 P49760 4/20 0.44
▸ DYRK1A Q13627 4/20 0.44
▸ ROCK1 Q13464 4/20 0.44
▸ CLK4 Q9HAZ1 4/20 0.44
▸ DAPK3 O43293 3/20 0.44
▸ DYRK3 O43781 3/20 0.44
▸ ROCK2 O75116 3/20 0.44
▸ MAP4K4 O95819 3/20 0.44
▸ CDK1 P06493 3/20 0.44
▸ CDK2 P24941 3/20 0.44
▸ MARK3 P27448 3/20 0.44
▸ TYK2 P29597 3/20 0.44
▸ CDK5 Q00535 3/20 0.44
▸ PRKCD Q05655 3/20 0.44
▸ PKN2 Q16513 3/20 0.44
▸ MARK2 Q7KZI7 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30633303 0.90 JAK2 (0.48) JAK2JAK3PLK4AURKBCLK2
SCHEMBL30633306 0.90 CNR1 (0.51) JAK2JAK3PLK4AURKBCLK2
SCHEMBL26686099 0.89 JAK2 (0.56) JAK2JAK3PLK4AURKBCLK2
SCHEMBL30633331 0.89 JAK2 (0.56) JAK2JAK3PLK4AURKBCLK2
SCHEMBL30633377 0.88 JAK2 (0.51) JAK2JAK3PLK4AURKBCLK2
SCHEMBL30633326 0.85 DYRK1A (0.45) JAK2CLK2DYRK1AMAPK1CLK3
SCHEMBL30633336 0.84 KDR (0.51) JAK2PLK4AURKBCLK2ROCK1
SCHEMBL30633386 0.84 JAK2 (0.41) JAK2JAK3PLK4AURKBCLK2
SCHEMBL30633320 0.84 KDR (0.46) JAK2JAK3PLK4AURKBCLK2
SCHEMBL30633368 0.79 JAK2 (0.38) JAK2JAK3PLK4AURKBCLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO disclosed
Send feedback